CD

Chiraag Deepak Tripathi

Active Director Designated Partner DIN 10395833
DIN 10395833 First appointment Nov 2023 Primary industry Wood
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Chiraag Deepak Tripathi

Data last updated:

Chiraag Deepak Tripathi is a Designated Partner at Able Biomedicals Llp (since 2023). The company operates in Wood.

DIN 10395833
Primary Designation Designated Partner
Industry Wood
First Appointment 18 Nov 2023
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner18 Nov 20232023Active

Board colleagues of Chiraag Deepak Tripathi

NameDINCompanyDesignation
Namita Deepak Tripathi01486647Able Biomedicals LlpDesignated Partner
Ujjwal Deepak Tripathi10395834Able Biomedicals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Able Biomedicals Llp
Premium access

Shareholding and investment profile for Chiraag Deepak Tripathi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chiraag Deepak Tripathi

Chiraag Deepak Tripathi currently holds 1 directorship: Able Biomedicals Llp (Designated Partner, since 18 Nov 2023).

Chiraag Deepak Tripathi was first appointed on 18 Nov 2023 as Designated Partner at Able Biomedicals Llp.

The current boards of Chiraag Deepak Tripathi's companies include Namita Deepak Tripathi (Able Biomedicals Llp), Ujjwal Deepak Tripathi (Able Biomedicals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available